SCHEMBL32665447

SCHEMBL32665447

O=C1C=CC(=O)N1C1CN(c2ccc(O)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.50
HSP90AA1 P07900 2/20 0.50
PKM P14618 2/20 0.50
MGLL Q99685 2/20 0.50
MAPK1 P28482 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
KMT2A Q03164 2/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
APAF1 O14727 1/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
CCR6 P51684 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
KDM4E B2RXH2 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665425 0.87 TDP1 (0.44) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL32665615 0.77 TDP1 (0.41) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL32665103 0.73 ALDH1A1 (0.33) TDP1HSP90AA1PKMMGLLKMT2A
SCHEMBL31142660 0.69 KMT2A (0.47) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL140288 0.68 MGLL (1.00) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL32665497 0.65 KIF11 (0.44) KMT2AMEN1MAPTHTR7KIF11
SCHEMBL19315059 0.64 KMT2A (0.56) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL7041242 0.64 MAPT (0.68) TDP1PKMKMT2AGAAMEN1
SCHEMBL10901620 0.64 MGLL (0.36) TDP1HSP90AA1PKMMGLLMAPK1
SCHEMBL209765 0.64 ALDH1A1 (0.46) HSP90AA1PKMMGLLMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A TDP1 3545/4885HSP90AA1 1275/4885PKM 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.